Celeste Bello, MD, Moffitt Cancer Center, Tampa, FL

Recorded on November 21, 2024

Celeste Bello, MD
Senior Member, Department of Malignant Hematology
Moffitt Cancer Center
Tampa, FL
Join us as we dive into bispecific antibodies with Dr. Celeste Bello from Moffitt Cancer Center, exploring their mechanisms of action, current indications in lymphoma, and strategies for patient selection and administration. Dr. Bello also discusses side effects, management strategies, and emerging trends in bispecific therapies. Tune in today to learn more! Feedback

Lynn Gooden, BSN, RN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN and Cassie Osborne, MSN, RN, OCN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN

Recorded on November 14, 2024

Lynn Gooden, BSN, RN, ONN-CG
Oncology Navigation and Survivorship Manager
Oncology Navigation
Community Health Network MD Anderson Cancer Center
Indianapolis, IN
Cassie Osborne, MSN, RN, OCN, ONN-CG
Oncology Nurse Navigator
Oncology Navigation-Hematology/Sarcoma/Brain/Skin
Community Health Network MD Anderson Cancer Center
Indianapolis, IN
Join us for this important episode, as Lynn Gooden and Cassie Osborne, nurses from the Community Health Network MD Anderson Cancer Center in Indianapolis, discuss mental health challenges faced by survivors of cancer, including the impact of long-term and late effects. They explore how a multidisciplinary team can address both physical and psychosocial needs, and caregiver involvement in decision-making and support. Resources are also highlighted for healthcare professional education, along with support resources for survivors and caregivers to enhance survivorship. Tune in to today for this insightful discussion! Feedback

This episode is supported by Genentech, A Member of the Roche Group.

Kerry A. Rogers, MD, The Ohio State University, Columbus, OH

Recorded on October 29, 2024

Kerry A. Rogers, MD
Associate Professor
Division of Hematology
The Ohio State University
Columbus, OH
Tune in for this comprehensive overview of Chronic Lymphocytic Leukemia (CLL) with Dr. Kerry Rogers from The Ohio State University. She covers key risk factors, signs and symptoms, and the critical decision-making process between monitoring and initiating treatment. Also explored are treatment goals with consideration to how strategies may vary for different subsets of patients, and discussion on new therapies. Additionally, Dr. Rogers addresses side effect management and resources available to support both patients and their families. Listen to this informative episode today! Feedback

Jennifer R. Rushton, MD, Clinical Pathology Associates and the Baptist Health System, San Antonio, TX and Eric Severson, MD, PhD, Labcorp Oncology, Shelton, CT

Recorded on July 2, 2024

Join us, as we dive into the crucial topic of biomarker testing with Dr. Jennifer Rushton from Clinical Pathology Associates and the Baptist Health System, and Dr. Eric Severson from Labcorp Oncology. They explore the role of the healthcare team in integrating biomarker testing into clinical practice and decision-making, as well as strategies for effective patient communication about its importance and implications. They also share their perspectives on the future of biomarker testing. Tune in today to learn more!

Jennifer R. Rushton, MD
Clinical Pathology Associates
Medical Director, Pathology and Laboratory Medicine
Baptist Health System
San Antonio, TX Eric Severson, MD, PhD
Executive Director Medical Affairs and Evidence Generation
Labcorp Oncology
Shelton, CT

Feedback

This episode is supported by Labcorp Oncology.

Stacie B. Dusetzina, PhD, Vanderbilt University Medical Center, Nashville, TN and Bethany Lilly, JD, The Leukemia & Lymphoma Society, Rye Brook, NY

Recorded on September 20, 2024

Tune in to this informative episode as Dr. Stacie Dusetzina from Vanderbilt University and Bethany Lilly from The Leukemia & Lymphoma Society’s Office of Public Policy simplify the complexities of Medicare, and how healthcare professionals can help their patients navigate these decisions for better care outcomes. They discuss how plan choices affect access to cancer treatment and the financial burden of high-cost medications. They also examine the recent changes brought by the Inflation Reduction Act and what they mean for Medicare beneficiaries. Listen today to learn more about helping your patients make informed decisions, including helpful resources, in this important aspect of healthcare!

Stacie B. Dusetzina, PhD
Professor, Health Policy
Ingram Professor of Cancer Research
Vanderbilt University Medical Center
Nashville, TN Bethany Lilly, JD
Executive Director, Public Policy
The Leukemia & Lymphoma Society
Rye Brook, NY

Resources mentioned in this episode:

• American Cancer Society
• Centers for Medicare and Medicaid Services
• Medicare Plan Finder
• State Health Insurance Assistance Program (SHIP)
• The Leukemia & Lymphoma Society
• Triage Cancer

Feedback

Alex F. Herrera, MD, City of Hope Medical Center, Duarte, CA

Recorded on June 27, 2024

Alex F. Herrera, MD
Associate Professor
Chief, Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation
Associate Medical Director, Briskin Center for Clinical Research & City of Hope
Duarte Clinical Trials Office
City of Hope Medical Center
Duarte, CA
In this episode, Dr. Alex Herrera from City of Hope explores the intricacies of Hodgkin lymphoma, from diagnosis and monitoring techniques to treatment goals and options. He discusses emerging therapies, including the significance of clinical trials, strategies for managing side effects, long-term effects of treatment, and resources for healthcare professionals, patients, and families. Tune in to learn more today! Feedback

Shira Dinner, MD, Northwestern University, Chicago, IL and Tom Martin, MD, University of California San Francisco, San Francisco, CA

Recorded on September 9, 2024

Join us for this special episode, recorded at the Twelfth Annual Meeting of the Society of Hematologic Oncology in Houston, TX! Guest host and conference attendee, Lauren Berger, Senior Director of Professional Education and Engagement at The Leukemia & Lymphoma Society, speaks with Dr. Shira Dinner, from Northwestern University, and Dr. Tom Martin, from University of California San Francisco, about their insights and key takeaways from the conference. Learn more by tuning in here!

Shira Dinner, MD
Associate Professor
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, IL Tom Martin, MD
Clinical Professor of Medicine, Division of Hematology/Oncology
Director, Clinical Research, Hematologic Malignancies Program
Co-Leader, Cancer Immunology and Immunotherapy
Associate Director, Myeloma Program
University of California San Francisco
San Francisco, CA Feedback

Krish Patel, MD, Swedish Cancer Institute, Seattle, WA

Recorded on June 6, 2024

Krish Patel, MD
Director, Lymphoma Program
Director, Hematologic Malignancies and Cellular Therapy
Swedish Cancer Institute
Seattle, WA
Join us as Dr. Krish Patel from Swedish Cancer Institute explores mantle cell lymphoma, including the goals and latest advancements in treatment. He also provides insights on treating relapsed/refractory cases, discusses effective strategies for managing side effects, and highlights the importance of communication between patients and healthcare professionals for optimal care. Tune in to stay up to date on mantle cell lymphoma today! Feedback

Ximena Jordan-Bruno, MD, University of Pennsylvania, Philadelphia, PA

Recorded on June 4, 2024

Ximena Jordan-Bruno, MD
Assistant Professor, Division of Hematology/Oncology
University of Pennsylvania
Philadelphia, PA
Join us for this fascinating episode, where Dr. Ximena Jordan-Bruno from the University of Pennsylvania explores hereditary myeloid and hematologic disorders, covering their classifications, mutations, and related germline predisposition syndromes. Learn about key clinical features, diagnostic approaches, the role of genetic counseling, and future research directions. Tune in today for valuable updates to enhance your understanding and practice! Feedback

Susan Hong, MD, Virginia Commonwealth University, Richmond, VA

Recorded on May 21, 2024

Susan Hong, MD
Director, Cancer Survivorship Program, Massey Comprehensive Cancer Center
Associate Professor, School of Medicine Internal Medicine
Virginia Commonwealth University
Richmond, VA Tune in as Dr. Susan Hong, Cancer Survivorship Program Director at Virginia Commonwealth University’s Massey Cancer Center, discusses survivorship care in adults. She explores the intersection of healthcare professional and patient goals in survivorship care, as well as disparities and challenges impacting access and follow-up. Dr. Hong offers strategies to improve adherence to survivorship care and communication between survivors and primary care practitioners. She also shares educational resources for healthcare professionals, patients, and caregivers to support effective survivorship care. Listen to this informative episode today! Feedback

This episode is supported by Genentech, Inc. & Biogen and Merck & Co., Inc.

David Dean, DDS, MSD, DABOM, FDS RCSEd, Fred Hutchinson Cancer Center and University of Washington School of Dentistry, Seattle, WA Recorded on April 25, 2024 David Dean, DDS, MSD, DABOM, FDS RCSEd Director, Oral Medicine Fred Hutchinson Cancer Center Clinical Associate Professor University of Washington School of Dentistry Seattle, WA Join us, as Dr. David Dean from Fred Hutchinson Cancer Center and the University of Washington School of Dentistry uncovers essential aspects of oral health in cancer care, including symptoms that may indicate a blood cancer, common dental complications that arise from treatment, and insights into preventative care. Dr. Dean also addresses special considerations for patients with cancer needing dental care and strategies for healthcare providers to provide optimal support for patients navigating dental challenges. Tune in to learn more today!